SomaKit TOC™ is a novel kit developed by AAA for the preparation of gallium Ga 68 edotreotide solution for injection used for localisation of primary tumors and metastases in patients with confirmed or suspected well-differentiated gastroenteropancreatic neuroendocrine tumors (GEP-NET) in adults. The kit has been designated as an orphan drug by the EMA and the FDA. SomaKit TOC™ is the first ready-to-use EMA approved kit for radiopharmaceutical preparation using Ga 68 as a positron emitter.

Advantages:

  • Fast and reliable production method of Ga-68 DOTA-TOC
  • Removes need for expensive peptide synthesis units
  • Higher activity available per synthesis compared to synthesis unit production
  • Fully EMA approved